Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research Article

Real-time Imaging of Apoptosis Induction of Human Breast Cancer Cells by the Traditional Chinese Medicinal Herb Tubeimu

MINGXIN HU, MING ZHAO, CHAO AN, MENG YANG, QUANWANG LI, YONG ZHANG, ATSUSHI SUETSUGU, YASUNORI TOME, SHUYA YANO, YANLING FU, ROBERT M. HOFFMAN and KAIWEN HU
Anticancer Research July 2012, 32 (7) 2509-2514;
MINGXIN HU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MING ZHAO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHAO AN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MENG YANG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
QUANWANG LI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YONG ZHANG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ATSUSHI SUETSUGU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUNORI TOME
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHUYA YANO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YANLING FU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROBERT M. HOFFMAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAIWEN HU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kaiwenh{at}163.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Traditional Chinese Medicine (TCM) has been used for thousands of years, including treatment for cancer. Use of modern technology and the scientific method to evaluate the efficacy of TCM for cancer should enable its more widespread use. In the present study, the efficacy of the TCM tubeimu, extracted from the tuber of the plant Bolbostemma paniculatum, on the MDA-MB-231 human breast cancer cell line was evaluated. The MDA-MB-231 cell line was engineered to express red fluorescent protein (RFP) in the cytoplasm and green fluorescent protein (GFP) linked to histone H2B in the nucleus, which allows real-time imaging of nuclear-cytoplasmic dynamics. Apoptosis was readily visualized in these cells by nuclear shape changes and fragmentation. The MDA-MB-231 RFP-GFP cells were cultured either in two-dimensions on plastic or in three-dimensions on Gelfoam®. Cells were treated with a dichloromethane extract of fresh tubeimu. Apoptosis was further monitored by DNA fragmentation determined by gel electrophoresis. Tubeimu induced apoptosis of MDA-MB-231 cells, as observed by fluorescence microscopy, as early as 24 hours of treatment in vitro in two-dimensional culture. By 48 hours' treatment, DNA fragmentation could be observed. The frequency of apoptosis increased through at least 72 hours' treatment, with most of the cells being killed. Tubeimu also induced apoptosis of MDA-MB-231 cells in three-dimensional culture on Gelfoam®, but to a lesser extent than in 2D culture. The results of the present study indicate the potential of tubeimu in breast cancer therapy.

  • Traditional Chinese Medicine
  • TCM
  • breast cancer cells
  • GFP
  • RFP
  • apoptosis
  • real-time imaging
  • tubeimu
  • Bolbostemma paniculatum

The tuber (tubeimu) of Bolbostemma paniculatum (Maxim) Franquet (Cucurbitaceae), a traditional Chinese medicinal (TCM) plant, was listed in the Supplement to the Compendium of Materia Medica, written during the Qing Dynasty in 1765 (1).

Tubeimu has been shown to be active against nasopharyngeal carcinoma (2), cervical carcinoma (3), lung cancer (4), liver cancer (5), stomach cancer (6), colon cancer (7), and renal carcinoma (8). However, there have not been reports on the efficacy of tubeimu on breast cancer.

Our laboratory has developed a method for real-time imaging of apoptosis (9-11) by labeling cells with fluorescent proteins. To investigate the efficacy of tubeimu on breast cancer, we used the MDA-MB-231 human breast cancer cell line expressing red fluorescent protein (RFP) in the cytoplasm and green fluorescent protein (GFP) linked to histone H2B in the nucleus. Such dual-color cells are a useful tool for visualizing nuclear-cytoplasmic dynamics, including apoptosis, in real time, under fluorescence microscopy (9, 12).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Non-apoptotic and apoptotic MDA-MB-231 RFP-GFP cells. A: Non-apoptotic cells. B: Apoptotic cells.

Efficacy of tubeimu was evaluated on MDA-MB-231-RFP-GFP human breast cancer cells in both 2D culture on plastic dishes and 3D culture on Gelfoam®, where cells take their natural shape and form 3D structures (11). Cancer cells and tumors cultured in a 3D gel-supported primary culture system, such as Gelfoam®, respond to drugs in an in vivo-like way (13).

Materials and Methods

Cell line. MDA-MB-231 RFP-GFP human breast cancer cells (AntiCancer Inc., San Diego, CA, USA) were cultured in RPMI-1640 medium with 10% fetal bovine serum (FBS) at 37°C with 5% CO2.

2D Culture and drug testing. Fresh tubeimu was extracted with dichloromethane and dissolved in phosphate-buffered saline (PBS) (for stock and working solutions), and then mixed with RPMI-1640 at concentrations of 15 μg/ml, 20 μg/ml, and 40 μg/ml. A total of 106 MDA-MB-231 RFP-GFP cells were seeded on 35 mm plastic dishes for 2D culture or on Gelfoam® (Pharmacia & Upjohn Co., Kalamazoo, MI, USA) for 3D culture, for tubeimu testing (please see below). Treatment was either for 24, 48 or 72 h. Untreated cultures served as controls. Each treatment or control was tested in triplicate.

Three-dimensional Gelfoam® culture and drug testing. Gelfoam® was cut in 10×10×3 mm pieces and soaked in RPMI-1640 medium. 106 MDA-MB-231-RFP-GFP cells were seeded on hydrated Gelfoam®, in RPMI-1640 medium with 10% FBS, with sufficient volume to cover the Gelfoam® in 35 mm dishes. Care was taken so that cells did not float away from the Gelfoam® and scatter in the medium. Tubeimu was prepared, as above, at 20 μg/ml and 25 μg/ml, for testing in Gelfoam® 3D culture.

Confocal imaging. A Fluorview FV1000 fluorescence confocal microscope (Olympus, Tokyo, Japan) was used (14). Images of MDA-MB-231 RFP-GFP cells (Figure 1) were acquired at 24, 48, and 72 h of treatment with tubeimu in 2D or 3D culture.

DNA gel electrophoresis. Treated and control MDA-MB-231 GFP-RFP cells (0.5-1×106) were placed in 1.5 ml microcentrifuge tubes and centrifuged for 5 min at 500 ×g. The supernatant was removed with a pipette. The pelleted cells were then lysed in 35 μl Tris EDTA (TE) lysis buffer by gentle pipetting. Care was taken not to shear the DNA. RNAse A solution (5 μl) was added to the lysate mix and the tubes were incubated at 37°C for 5-10 min. Proteinase K solution (5 μl) was added to each tube and mixed and the tubes were then incubated at 50°C for 30 min or longer until the lysates became clear. Ammonium acetate solution (5 μl) was added, the solution was mixed and kept at −20°C for at least 10 min. The sample was then centrifuged for 10 minutes (16000 ×g) to precipitate the DNA. The supernatant was removed and the DNA pellet was washed with 0.5 ml of ice-cold 70% ethanol. The DNA pellet was then air dried for 10 minutes at room temperature. The dried DNA pellet was dissolved in 30 μl DNA suspension buffer and then the sample (20 μl) was loaded onto a 1% Tris-acetate agarose gel containing 0.5 μg/ml ethidium bromide in both the gel and the running buffer. The gel was electrophoresed at 5 V/cm for 1-2 h, stained in TE/ethidium bromide for 10-15 min, and visualized by transillumination under UV light and photographed.

Statistical analysis. The Student's t-test was used to obtain p-values in order to compare tubeimu-treated and untreated cultures.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

A, B. Apoptosis and killing of MDA-MB-231-RFP-GFP cells by tubeimu in 2D culture. MDA-MB-231 cells were cultured on plastic dishes in RPMI-1640 medium. The induction of apoptosis by tubeimu in MDA-MB-231 RFP-GFP cells in 2D culture was dose- and time-dependent as observed after treatment with 15 μg/ml, 20 μg/ml, and 40 μg/ml tubeimu for 24, 48, and 72 hours. The decrease in cell number was also dose- and time-dependent compared to untreated control (p<0.01). Bar=100 μm. ([rhombus6]=p<0.05, [pentastar2]=p<0.01).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Apoptosis and killing of MDA-MB-231 cells by tubeimu in 3D culture. MDA-MB-231 cells were cultured on Gelfoam® in RPMI-1640 medium and treated with 20 μg/ml and 25 μg/ml tubeimu for 24, 48 and 72 hours. Bar=100 μm.

Results and Discussion

Induction of apoptosis of MDA-MA-231 RFP-GFP human breast cancer cells by tubeimu in 2D culture. Apoptosis was observed in the tubeimu-treated MDA-MD-231 RFP-GFP cells growing on plastic dishes in 2D culture by nuclear size changes and progressive nuclear fragmentation using confocal imaging (Figure 1). The MDA-MB-231 RFP-GFP cells displayed obvious apoptotic morphological changes after being treated with tubeimu for 24 h. Nuclear size changes, chromatin condensation and progressive nuclear fragmentation were observed (Figure 1). The induction of apoptosis by tubeimu in MDA-MB-231 RFP-GFP cells in 2D culture was dose- and time-dependent, as observed after treatment with 15 μg/ml, 20 μg/ml, and 40 μg/ml tubeimu for 24, 48, and 72 h (Figure 2A, B). The decrease in cell number was also dose- and time-dependent (p<0.01) (Figure 2A). Tubeimu treatment at 40 μg/ml resulted in irregular morphology of the cells and the cell number decreased sharply (Figure 2A). Almost no live cells remained after 48 h treatment with 40 μg/ml tubeimu (Figure 2A). By 72 h, there were almost no live cells remaining even after treatment with 20 μg/ml tubeimu (Figure 2A).

Induction of apoptosis of MDA-MB-231 RFP-GFP human breast cancer cells by tubemu in 3D culture. In 3D Gelfoam® culture, the MDA-MB-231 RFP-GFP cells were more resistant to tubeimu when tested at 20 μg/ml and 25 μg/ml for 24, 48, and 72 h (Figure 3). In 2D culture, the difference between the three different tubeimu dosages and the three different timepoints were more obvious than in 3D culture (Figures 2A, 3 and 4). In 3D Gelfoam® culture, cancer cells assume their natural shape (more in vivo-like) (15). In addition, the cells in 3D Gelfoam® culture attach more tightly to each other and have a broader contact area with each other than that in 2D culture, which may protect the cells from entering apoptosis. However, in the control group in 3D culture at all time points, the cell number increased, in contrast with the number of tubeimu-treated cells which decreased in number over this time period (p<0.01) (Figures 3 and 4). In 3D Gelfoam® culture, the cell morphology changed in the treated cells compared with that of the control group (Figure 3).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Comparison of apoptosis in MDA-MB-231 RFP-GFP cells induced by tubeimu in 2D and 3D cultures. MDA-MB-231 RFP-GFP cells were cultured in 2D on plastic dishes and 3D on Gelfoam® in RPMI-1640 medium. Please see Figures 2 and 3 for details. The frequency of apoptosis in treated and control cultures was compared ([pentastar2][pentastar2]=p<0.01).

Induction of DNA fragmentation in MDA-MD-231 RFP-GFP cells by tubeimu. Agarose-gel electrophoresis detected DNA fragmentation in the MDA-MB-231 RFP-GFP cells after 48 h treatment with tubeimu in 2D culture, with an increase at 72 h. In contrast, morphological changes observed by fluorescence microscopy revealed apoptosis induction by tubeimu by 24 h. Fluoresence microscopy of cancer cells labeled with GFP in the nucleus and RFP in the cytoplasm is therefore more sensitive than DNA electrophoresis for detecting apoptosis (Figure 5).

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Fragmentation of MDA-MB-231 RFP-GFP cells after tubeimu treatment. Lanes contain DNA from the following cultures: (1) tubeimu at 15 μg/ml for 72 hours in 2D culture, (2) tubeimu at 15 μg/ml for 48 hours, (3) tubeimu at 15 μg/ml for 24 hours, (4) untreated control, (5) DNA marker (100bp), (6) DNA marker (smallest size is 1,000 bp).

TCM is a vast potential resource for cancer treatment. However, in order to determine which herbs or their combination have anticancer activity that can be used widely, modern methods must be used to evaluate them. In the present report, we utilized human breast cancer cells engineered to express RFP in the cytoplasm and GFP in the nucleus (9-11). These cells clearly report nuclear-cytoplamic dynamics in real time and are ideal to reveal the onset and progression of treatment-induced apoptosis. The findings of this report, demonstrate the potential of tubeimu for cancer therapy.

Acknowledgements

This study was supported in part by National Cancer Institute grant CA132971.

Footnotes

  • Conflict of Interest

    None of the Authors have a conflict of interest with this study.

  • Received February 4, 2012.
  • Revision received March 1, 2012.
  • Accepted March 6, 2012.
  • Copyright© 2012 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Yu TX,
    2. Ma RD,
    3. Yu LJ
    : Structure–activity relationship of tubeimosides in anti-inflammatory, antitumor and antitumor-promoting effects. Acta Pharmacol Sin 22(5): 463-468, 2001.
    OpenUrlPubMed
  2. ↵
    1. Weng XY,
    2. Ma RD,
    3. Yu LJ
    : Apoptosis of human nasopharyngeal carcinoma CNE-2Z cells induced by tubeimoside I. Ai Zheng Chinese J Cancer 22(8): 806-811, 2003.
    OpenUrl
  3. ↵
    1. Ma RD,
    2. Yu LJ,
    3. Su WM,
    4. Shao HY,
    5. Hao MN,
    6. He DM,
    7. Huang LZ
    : Induction of cell cycle arrest and apoptosis by tubeimoside I isolated from Bolbostemma paniculatum in HeLa cells. Chinese Clin Pharmacol Therap 9(3): 261-269, 2004.
    OpenUrl
  4. ↵
    1. Wang CX,
    2. Ma RD,
    3. Yu LJ
    : Effect of tubeimu sapion on invasion of human high metastasis lung cancer cell PGCL3. Chinese Clin Pharmacol Therap 11(1): 39-44, 2006.
    OpenUrl
  5. ↵
    1. Wang YS,
    2. Deng LH,
    3. Zhong HZ,
    4. Wang YJ,
    5. Jiang XM,
    6. Chen J
    : Natural plant extract tubeimoside I promotes apoptosis-mediated cell death in cultured human hepatoma (HepG2) cells. Biol Pharm Bull 34(6): 831-838, 2011.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Li M,
    2. Yu JX,
    3. Shun D,
    4. Qian XS,
    5. Hu SX,
    6. Ye HJ
    : Study on apoptosis and differentiation of stomach cancer cell induced by tubeimu. Chinese J Integrated Trad Western Med 22: 201-203, 2002.
    OpenUrl
  7. ↵
    1. Yu C,
    2. Qui ZY,
    3. Tang WX,
    4. Li HZ
    : Apoptosis of SW480 induced by sapion of tubeimu. Chinese Pharmcol Bull 22(7): 880-884, 2006.
    OpenUrl
  8. ↵
    1. Li XG,
    2. Nan XY,
    3. Dang JG
    : Study on the effect of tubeimu on human renal cancer cell. Chinese J Urol 18(8): 503, 1997.
    OpenUrl
  9. ↵
    1. Yamamoto N,
    2. Jiang P,
    3. Yang M,
    4. Xu M,
    5. Yamauchi K,
    6. Tsuchiya H,
    7. Tomita K,
    8. Wahl GM,
    9. Moossa AR,
    10. Hoffman RM
    : Cellular dynamics visualized in live cells in vitro and in vivo by differential dual-color nuclear-cytoplasmic fluorescent-protein expression. Cancer Res 64: 4251-4256, 2004.
    OpenUrlAbstract/FREE Full Text
    1. Jiang P,
    2. Yamauchi K,
    3. Yang M,
    4. Tsuji K,
    5. Xu M,
    6. Maitra A,
    7. Bouvet M,
    8. Hoffman RM
    : Tumor cells genetically labeled with GFP in the nucleus and RFP in the cytoplasm for imaging cellular dynamics. Cell Cycle 5: 1198-1201, 2006.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Hoffman RM,
    2. Yang M
    : Subcellular imaging in the live mouse. Nature Prot 1: 775-782, 2006.
    OpenUrl
  11. ↵
    1. Vescio RA,
    2. Redfern CH,
    3. Nelson TJ,
    4. Ugoretz S,
    5. Stern PH,
    6. Hoffman RM
    : In vivo-like drug response of human tumors growing in three-dimensional, gel-supported, primary culture. Proc Natl Acad Sci USA 84: 5029-5033, 1987.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Freeman A,
    2. Hoffman RM
    : In vivo-like growth of human tumors in vitro. Proc Natl Acad Sci USA 83: 2694-2698, 1986.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Uchugonova A,
    2. Duong J,
    3. Zhang N,
    4. König K,
    5. Hoffman RM
    : The bulge area is the origin of nestin-expressing pluripotent stem cells of the hair follicle. J Cell Biochem 112: 2046-2050, 2011.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Hoffman RM
    : Histocultures and their use. In: Encyclopedia of Life Sciences. John Wiley and Sons, Ltd: Chichester 2010, published online. DOI: 10.1002/9780470015902.a0002573.pub2.
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 32, Issue 7
July 2012
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Real-time Imaging of Apoptosis Induction of Human Breast Cancer Cells by the Traditional Chinese Medicinal Herb Tubeimu
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Real-time Imaging of Apoptosis Induction of Human Breast Cancer Cells by the Traditional Chinese Medicinal Herb Tubeimu
MINGXIN HU, MING ZHAO, CHAO AN, MENG YANG, QUANWANG LI, YONG ZHANG, ATSUSHI SUETSUGU, YASUNORI TOME, SHUYA YANO, YANLING FU, ROBERT M. HOFFMAN, KAIWEN HU
Anticancer Research Jul 2012, 32 (7) 2509-2514;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Real-time Imaging of Apoptosis Induction of Human Breast Cancer Cells by the Traditional Chinese Medicinal Herb Tubeimu
MINGXIN HU, MING ZHAO, CHAO AN, MENG YANG, QUANWANG LI, YONG ZHANG, ATSUSHI SUETSUGU, YASUNORI TOME, SHUYA YANO, YANLING FU, ROBERT M. HOFFMAN, KAIWEN HU
Anticancer Research Jul 2012, 32 (7) 2509-2514;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Mechanism of CDK4/6 Inhibitor Resistance in Hormone Receptor-positive Breast Cancer and Alternative Treatment Strategies
  • Brucea javanica Increases Survival and Enhances Gemcitabine Efficacy in a Patient-derived Orthotopic Xenograft (PDOX) Mouse Model of Pancreatic Cancer
  • Ethanolic Extract of Traditional Chinese Medicine (TCM) Gamboge Inhibits Colon Cancer via the Wnt/Beta-Catenin Signaling Pathway in an Orthotopic Mouse Model
  • Anti-metastatic Efficacy of Traditional Chinese Medicine (TCM) Ginsenoside Conjugated to a VEFGR-3 Antibody on Human Gastric Cancer in an Orthotopic Mouse Model
  • Color-coded Live Imaging of Heterokaryon Formation and Nuclear Fusion of Hybridizing Cancer Cells
  • Use of {alpha}v Integrin Linked to Green Fluorescent Protein in Osteosarcoma Cells and Confocal Microscopy to Image Molecular Dynamics During Lung Metastasis in Nude Mice
  • Combination Efficacy of Astragalus membranaceus and Curcuma wenyujin at Different Stages of Tumor Progression in an Imageable Orthotopic Nude Mouse Model of Metastatic Human Ovarian Cancer Expressing Red Fluorescent Protein
  • Early Reporting of Apoptosis by Real-time Imaging of Cancer Cells Labeled with Green Fluorescent Protein in the Nucleus and Red Fluorescent Protein in the Cytoplasm
  • The Use of Living Cancer Cells Expressing Green Fluorescent Protein in the Nucleus and Red Fluorescence Protein in the Cytoplasm for Real-time Confocal Imaging of Chromosome and Cytoplasmic Dynamics During Mitosis
  • Google Scholar
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire